SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-066707
Filing Date
2019-11-22
Accepted
2019-11-22 17:15:43
Documents
13
Period of Report
2019-11-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm19236191_8k.htm   iXBRL 8-K 47516
  Complete submission text file 0001104659-19-066707.txt   269241

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA celg-20191121.xsd EX-101.SCH 3686
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celg-20191121_def.xml EX-101.DEF 27275
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE celg-20191121_lab.xml EX-101.LAB 36906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celg-20191121_pre.xml EX-101.PRE 25900
9 EXTRACTED XBRL INSTANCE DOCUMENT tm19236191_8k_htm.xml XML 5122
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 191242498
SIC: 2834 Pharmaceutical Preparations